Literature DB >> 18799471

Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin.

D M O'Sullivan1, J Hinds, P D Butcher, S H Gillespie, T D McHugh.   

Abstract

OBJECTIVES: To investigate how the SOS response, an error-prone DNA repair pathway, is expressed following subinhibitory quinolone treatment of Mycobacterium tuberculosis.
METHODS: Genome-wide expression profiling followed by quantitative RT (qRT)-PCR was used to study the effect of ciprofloxacin on M. tuberculosis gene expression.
RESULTS: Microarray analysis showed that 16/110 genes involved in DNA protection, repair and recombination were up-regulated. There appeared to be a lack of downstream genes involved in the SOS response. qRT-PCR detected an induction of lexA and recA after 4 h and of dnaE2 after 24 h of subinhibitory treatment.
CONCLUSIONS: The pattern of gene expression observed following subinhibitory quinolone treatment differed from that induced after other DNA-damaging agents (e.g. mitomycin C). The expression of the DnaE2 polymerase response was significantly delayed following subinhibitory quinolone exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799471      PMCID: PMC2583065          DOI: 10.1093/jac/dkn387

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis.

Authors:  Helena I M Boshoff; Michael B Reed; Clifton E Barry; Valerie Mizrahi
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

3.  Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: apparent lack of correlation with LexA binding.

Authors:  P C Brooks; F Movahedzadeh; E O Davis
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

4.  Slow induction of RecA by DNA damage in Mycobacterium tuberculosis.

Authors:  K G Papavinasasundaram; C Anderson; P C Brooks; N A Thomas; F Movahedzadeh; P J Jenner; M J Colston; E O Davis
Journal:  Microbiology       Date:  2001-12       Impact factor: 2.777

5.  Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation.

Authors:  Stephen H Gillespie; Leroy L Voelker; Jane E Ambler; Chris Traini; Anne Dickens
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

6.  Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in Mycobacterium tuberculosis.

Authors:  Elaine O Davis; Edith M Dullaghan; Lucinda Rand
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

7.  Spontaneous and mutagen-induced deletions: mechanistic studies in Salmonella tester strain TA102.

Authors:  D E Levin; L J Marnett; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?

Authors:  Tobias Hampshire; Shamit Soneji; Joanna Bacon; Brian W James; Jason Hinds; Ken Laing; Richard A Stabler; Philip D Marsh; Philip D Butcher
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

9.  The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses.

Authors:  S L Kendall; F Movahedzadeh; S C G Rison; L Wernisch; T Parish; K Duncan; J C Betts; N G Stoker
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

10.  A recA-LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus.

Authors:  Carmelo Bisognano; William L Kelley; Tristan Estoppey; Patrice Francois; Jacques Schrenzel; Dongmei Li; Daniel P Lew; David C Hooper; Ambrose L Cheung; Pierre Vaudaux
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  19 in total

1.  Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance.

Authors:  Jyothi Padiadpu; Rohit Vashisht; Nagasuma Chandra
Journal:  Syst Synth Biol       Date:  2011-02-20

Review 2.  Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2.

Authors:  G L Drusano; William Hope; Alasdair MacGowan; Arnold Louie
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.

Authors:  V Balasubramanian; S Solapure; S Gaonkar; K N Mahesh Kumar; R K Shandil; Abhijeet Deshpande; Naveen Kumar; K G Vishwas; Vijender Panduga; Jitendar Reddy; Samit Ganguly; A Louie; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

4.  Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress.

Authors:  Giulia Manina; Anna Griego; Lalit Kumar Singh; John D McKinney; Neeraj Dhar
Journal:  EMBO J       Date:  2019-10-04       Impact factor: 11.598

Review 5.  Future target-based drug discovery for tuberculosis?

Authors:  Bavesh Davandra Kana; Petros C Karakousis; Tanya Parish; Thomas Dick
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

6.  Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.

Authors:  Maikel Boot; Susanna Commandeur; Amit K Subudhi; Meriem Bahira; Trever C Smith; Abdallah M Abdallah; Mae van Gemert; Joël Lelièvre; Lluís Ballell; Bree B Aldridge; Arnab Pain; Alexander Speer; Wilbert Bitter
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

7.  The complete genome sequence of Xanthomonas albilineans provides new insights into the reductive genome evolution of the xylem-limited Xanthomonadaceae.

Authors:  Isabelle Pieretti; Monique Royer; Valérie Barbe; Sébastien Carrere; Ralf Koebnik; Stéphane Cociancich; Arnaud Couloux; Armelle Darrasse; Jérôme Gouzy; Marie-Agnès Jacques; Emmanuelle Lauber; Charles Manceau; Sophie Mangenot; Stéphane Poussier; Béatrice Segurens; Boris Szurek; Valérie Verdier; Matthieu Arlat; Philippe Rott
Journal:  BMC Genomics       Date:  2009-12-17       Impact factor: 3.969

8.  Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model.

Authors:  Arnold Louie; Brandon Duncanson; Jenny Myrick; Michael Maynard; Jocelyn Nole; David Brown; Stephan Schmidt; Michael Neely; C A Scanga; Charles Peloquin; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons.

Authors:  Elizabeth G Gibson; Tim R Blower; Monica Cacho; Ben Bax; James M Berger; Neil Osheroff
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

10.  Novel role of phosphorylation-dependent interaction between FtsZ and FipA in mycobacterial cell division.

Authors:  Kamakshi Sureka; Tofajjen Hossain; Partha Mukherjee; Paramita Chatterjee; Pratik Datta; Manikuntala Kundu; Joyoti Basu
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.